BBC Morning Live doctor's warning as Chris Hoy reveals terminal cancer diagnosis
The six-time Olympic cycling champion told the Sunday Times his cancer is terminal and that he has between two and four years ...
FDA approves Astellas’ VYLOY for gastric cancer treatment
Astellas Pharma has gained approval from the US Food and Drug Administration (FDA) for VYLOY (zolbetuximab-clzb), in ...
standardmedia.co.ke2h
Alarm as cancer cases rise in Igembe and Buuri
Buuri and Igembe in Meru county have been identified as areas with high cancers cases.
LINDIS Biotech Receives Positive CHMP Opinion for KORJUNY(R) (catumaxomab) in the European Union
Upon authorization by the European Commission, KORJUNY® will be the only drug approved and available for the intraperitoneal treatment of malignant ascites in adults with epithelial cell adhesion ...
pharmaphorum4h
FDA clears Astellas' Vyloy as first claudin 18.2 cancer drug
Vyloy is the first CLDN18.2-targeting drug to reach the US market but has already been approved in Japan as well as in the EU ...
Targeted Oncology15h
The Targeted Pulse: Explore How a Community Practice Implemented Bispecific Antibody Therapy and Key Updates in Cancer Treatments
Promising results from the anti–LAG-3/anti–PD-1 combo for melanoma, FDA approval of inavolisib for PIK3CA-mutant breast cancer, significant survival benefits from talazoparib and enzalutamide in ...
healthandpharma18h
FDA Approves VYLOY™ as a New Targeted Therapy for Advanced Gastric and GEJ Cancer
The FDA has approved zolbetuximab-clzb (VYLOY) as a first-line targeted therapy, in combination with chemotherapy, for the ...
News Medical20h
Studies reveal unique challenges faced by younger patients with colorectal cancer
Younger adults with colon cancer tend to be diagnosed at a later stage and have more aggressive types of tumors.